Driving the expansion of mRNA into the therapeutic sphere
Cell & Gene Therapy Insights 2023; 9(3), 315–325
The advanced therapies industry is heavily engaged in capitalizing upon the extensive ‘proof of concept’ gained through the success of mRNA-based COVID-19 vaccines. Novel therapeutic applications in major disease areas, including oncology, continue to show promise in preclinical and early clinical studies, yet challenges remain.
Here, Elisa Manzotti, CEO of BioInsights, speaks to Alejandro Becerra, Thermo Fisher Scienitific, Andreas Kuhn, BioNTech, and Metin Kurtoglu, Cartesian Therapeutics to consider the ever-expanding reach of mRNA technology, exploring at a high level how and where it will impact the advanced therapies space moving forward. The panel will then dive deeper into specific trends, issues, and innovations in mRNA processing (particularly downstream) and analytical development, discussing key areas for improvement and corresponding solutions.
If you enjoy this article, you can also view the recorded Roundtable discussion here.